分子生物学用酵素・キット・試薬の世界市場2019-2023

◆英語タイトル:Global Molecular Biology Enzymes, Kits, and Reagents Market 2019-2023
◆商品コード:IRTNTR31035
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年3月29日
◆ページ数:121
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥327,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、分子生物学用酵素・キット・試薬の世界市場について調査・分析し、市場概要、市場環境、分子生物学用酵素・キット・試薬市場規模、エンドユーザー別(バイオテクノロジー及び製薬会社、病院及び診断センター、学術研究機関及び調査機関)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・分子生物学用酵素・キット・試薬の世界市場概要
・分子生物学用酵素・キット・試薬の世界市場環境
・分子生物学用酵素・キット・試薬の世界市場動向
・分子生物学用酵素・キット・試薬の世界市場規模
・分子生物学用酵素・キット・試薬の世界市場:業界構造分析
・分子生物学用酵素・キット・試薬の世界市場:エンドユーザー別(バイオテクノロジー及び製薬会社、病院及び診断センター、学術研究機関及び調査機関)
・分子生物学用酵素・キット・試薬の世界市場:地域別市場規模・分析
・分子生物学用酵素・キット・試薬の北米市場規模・予測
・分子生物学用酵素・キット・試薬のヨーロッパ・中東・アフリカ市場規模・予測
・分子生物学用酵素・キット・試薬のアジア太平洋市場規模・予測
・分子生物学用酵素・キット・試薬の主要国分析
・分子生物学用酵素・キット・試薬の世界市場:意思決定フレームワーク
・分子生物学用酵素・キット・試薬の世界市場:成長要因、課題
・分子生物学用酵素・キット・試薬の世界市場:競争環境
・分子生物学用酵素・キット・試薬の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market
The rising incidence of infectious diseases and genetic disorders will drive the market growth in the forecast period. Incidences of infections caused by pathogens including bacteria, fungi, viruses, and parasites are likely to contribute to the surging incidences of bladder infections and urinary tract infections. In addition, researchers are increasingly focusing on molecular biology for treating diseases using gene therapy and recombinant vaccines. This will further lead the molecular biology enzymes, kits, and reagents market growth during the forecast period. Technavio’s analysts have predicted that the molecular biology enzymes, kits, and reagents market will register a CAGR of 16% by 2023.
Market Overview
Increased use of proteins and reagents in biotechnology and pharmaceutical companies
One of the growth drivers of the global molecular biology enzymes, kits, and reagents market is the increased use of proteins and reagents in biotechnology and pharmaceutical companies. The increased use of proteins and reagents in biotechnology and pharmaceutical companies for applications such as drug discovery and development and in molecular biology research has propelled the growth of the market.
High costs and lack of reimbursement policies for genetic testing
One of the challenges in the growth of the global molecular biology enzymes, kits, and reagents market is the high costs and lack of reimbursement policies for genetic testing. The expensive nature of genetic tests leads to their decreased adoption among individuals, thereby reducing the overall demand for molecular biology enzymes, kits, and reagents necessary to perform these tests.
For the detailed list of factors that will drive and challenge the growth of the molecular biology enzymes, kits, and reagents market during 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately fragmented with the presence of several market players. Vendors in the market are focusing on offering a portfolio of diagnostic assays to hospitals, community clinics, pathology laboratories, and immunology laboratories for diagnosis of patients, pathogen detection, and viral load monitoring. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Biotechnology and pharmaceutical companies – Market size and forecast 2018-2023
• Hospitals and diagnostic centers – Market size and forecast 2018-2023
• Academic institutes and research organizations – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Rising use of molecular biology kits for disease diagnosis
• Increasing number of applications of molecular biology
• enzymes, kits, and reagents
• Technological advances in the life sciences industry
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: End-user – Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Biotechnology and pharmaceutical companies – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Biotechnology and pharmaceutical companies – Year-over-year growth 2019-2023 (%)
Exhibit 21: Hospitals and diagnostic centers – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Hospitals and diagnostic centers – Year-over-year growth 2019-2023 (%)
Exhibit 23: Academic institutes and research organizations – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Academic institutes and research organizations – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Agilent Technologies, Inc. – Vendor overview
Exhibit 46: Agilent Technologies, Inc. – Business segments
Exhibit 47: Agilent Technologies, Inc. – Organizational developments
Exhibit 48: Agilent Technologies, Inc. – Geographic focus
Exhibit 49: Agilent Technologies, Inc. – Segment focus
Exhibit 50: Agilent Technologies, Inc. – Key offerings
Exhibit 51: F. Hoffmann-La Roche Ltd – Vendor overview
Exhibit 52: F. Hoffmann-La Roche Ltd – Business segments
Exhibit 53: F. Hoffmann-La Roche Ltd – Organizational developments
Exhibit 54: F. Hoffmann-La Roche Ltd – Geographic focus
Exhibit 55: F. Hoffmann-La Roche Ltd – Segment focus
Exhibit 56: F. Hoffmann-La Roche Ltd – Key offerings
Exhibit 57: Illumina, Inc. – Vendor overview
Exhibit 58: Illumina, Inc. – Product segments
Exhibit 59: Illumina, Inc. – Organizational developments
Exhibit 60: Illumina, Inc. – Geographic focus
Exhibit 61: Illumina, Inc. – Segment focus
Exhibit 62: Illumina, Inc. – Key offerings
Exhibit 63: Merck KGaA – Vendor overview
Exhibit 64: Merck KGaA – Business segments
Exhibit 65: Merck KGaA – Organizational developments
Exhibit 66: Merck KGaA – Geographic focus
Exhibit 67: Merck KGaA – Segment focus
Exhibit 68: Merck KGaA – Key offerings
Exhibit 69: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 70: Thermo Fisher Scientific Inc. – Business segments
Exhibit 71: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 72: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 73: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 74: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 75: Validation techniques employed for market sizing



【掲載企業】

Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[分子生物学用酵素・キット・試薬の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆